RFK Jr.’s war on antidepressants is coming — and it will cost lives statnews.com
RFK Jr.’s war on antidepressants is coming — and it will cost lives – statnews.com Read Post »
New SupplySide editor outlines 2026 industry goals SupplySide Supplement Journal
New SupplySide editor outlines 2026 industry goals – SupplySide Supplement Journal Read Post »
This review article examines the current and potential applications of therapeutic peptides in orthopaedic medicine, including peptides such as BPC-157, discussing their mechanisms of action, clinical uses, and the obstacles to their development and implementation in orthopedic practice (Evidence level: Review). The article identifies key challenges in peptide therapeutics, such as stability, delivery mechanisms, and regulatory pathways, while also outlining future directions for research and clinical translation in orthopedic conditions. This represents a synthesis of existing literature rather than original research data from human clinical trials or animal studies.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Read Post »
This review article examines injectable peptide therapies, including BPC-157, relevant to orthopaedic and sports medicine practice, synthesizing existing evidence on mechanisms of action and clinical applications in musculoskeletal conditions. The review provides an overview of peptide-based therapeutic options and their potential role in orthopaedic treatment paradigms based on current literature. The evidence level is review article (synthesis of existing literature rather than original human clinical trials or animal model data).
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Read Post »
This research review examines TB4-Fragment’s potential for treating kidney disease. The peptide shows promise in protecting kidney cells, reducing inflammation, and preventing harmful scarring in both acute and chronic kidney injuries. While the results are encouraging across multiple studies, researchers note that peptide stability and delivery remain key challenges for practical clinical use.
Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Read Post »
This review article compared the anti-aging mechanisms of pyrroloquinoline quinone (PQQ) and nicotinamide-based compounds (NMN/NR), examining their effects on cellular processes and exploring potential synergistic benefits of combined use (evidence level: review of existing literature). The analysis evaluated how these compounds influence mitochondrial function, NAD+ metabolism, and oxidative stress pathways that are implicated in aging processes. The review synthesizes existing research to discuss the theoretical rationale for combining these compounds, though it does not present new primary data on their combined efficacy.
This review examines emerging multifunctional strategies in personalized regenerative medicine for wound repair, with relevance to orthopedic applications, including discussion of bioactive compounds like GHK-Cu. The article synthesizes current approaches that combine smart biomaterials, growth factors, and other therapeutic agents to enhance tissue healing outcomes. This is a review-level evidence source that synthesizes existing literature rather than reporting original clinical trial data.
New research identifies the specific molecular pathway BPC-157 uses to promote blood vessel formation – it works by stabilizing BACH1 protein through FBXO22 regulation. This breakthrough helps explain BPC-157’s proven regenerative effects across multiple organ systems and addresses the key scientific gap that has limited its clinical adoption. The research validates BPC-157’s angiogenic properties with concrete mechanistic evidence, strengthening the scientific foundation for practitioner use.
BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1. Read Post »
Ohio farmers face poor hay quality this winter Farm Progress
Ohio farmers face poor hay quality this winter – Farm Progress Read Post »
This study describes how emergency medical services developed a treatment protocol using methylene blue as an antidote for sodium nitrite poisoning. Sodium nitrite poisoning causes dangerous levels of methemoglobin in the blood, which prevents proper oxygen transport. Methylene blue was used by specialized paramedic teams to reverse this life-threatening condition. This represents a specific emergency medical application rather than a general health supplement use.
This narrative review examined the evidence for BPC-157, a synthetic peptide derived from gastric juice, in promoting musculoskeletal tissue healing across multiple tissue types. The review identified promising preclinical findings in animal models showing potential benefits for tendon, ligament, muscle, and bone healing, though human clinical evidence remains limited and mostly anecdotal. The evidence base is primarily animal model and in vitro studies, with very few human clinical trials available to date.
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Read Post »
This review article examines host defense peptides (HDPs), particularly KPV, as potential therapeutic agents for inflammatory bowel disease (IBD), discussing their mechanisms of action in modulating immune responses and reducing intestinal inflammation. The authors synthesize evidence from multiple study types—including in vitro, animal models, and human clinical investigations—to evaluate HDPs as a novel drug development strategy for IBD management. The evidence level is review article, which synthesizes findings across human clinical, animal model, and in vitro studies rather than presenting original research data.
Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease. Read Post »
